CSL Financials

CSL Stock Summary

CSL competes with Pmv Pharmaceuticals, Novo Nordisk, Kalvista Pharmaceuticals, ProKidney Corp, and Ventyx Biosciences. CSL Limited researches, develops, manufactures, markets, and distributes biopharmaceutical and allied products in Australia, the United States, Germany, the United Kingdom, Switzerland, China, and internationally. CSL Limited was founded in 1916 and is headquartered in Parkville, Australia. Csl operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 30000 people.

CSL Key Financial Ratios

There are many critical financial ratios that CSL's investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that CSL Limited reports annually and quarterly.

CSL Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining CSL's current stock value. Our valuation model uses many indicators to compare CSL value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across CSL competition to find correlations between indicators driving CSL's intrinsic value. More Info.CSL Limited is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers reporting about  0.41  of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for CSL Limited is roughly  2.46 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the CSL's earnings, one of the primary drivers of an investment's value.

CSL Limited Systematic Risk

Along with financial statement analysis, the daily predictive indicators of CSL help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of CSL Limited. We use our internally-developed statistical techniques to arrive at the intrinsic value of CSL Limited based on widely used predictive technical indicators. In general, we focus on analyzing CSL Pink Sheet price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build CSL's daily price indicators and compare them against related drivers.

When running CSL's price analysis, check to measure CSL's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CSL is operating at the current time. Most of CSL's value examination focuses on studying past and present price action to predict the probability of CSL's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CSL's price. Additionally, you may evaluate how the addition of CSL to your portfolios can decrease your overall portfolio volatility.